欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2604	Ropinirole hydrochloride	DR. REDDY'S LABORATORIES LIMITED Hyderabad IN	100003991;100000217	CEP 2021-240 - Rev 01	2025/10/22	Valid	31/10/2029	Chemical	2025/10/22	Major revision\|CEP granted\|22/10/2025; New application\|CEP granted\|31/10/2024
1768	Valaciclovir hydrochloride, Process B	ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD Xianju CN	100011826;100018693	CEP 2024-169 - Rev 02	2025/10/22	Valid	25/09/2029	Chemical	2025/10/22	Administrative procedure\|CEP granted\|22/10/2025; Minor revision\|CEP granted\|08/10/2025; New application\|CEP granted\|25/09/2024
3087	Ticagrelor	ZHEJIANG SUPOR PHARMACEUTICALS CO., LTD. Shaoxing CN	100022886;100031604	CEP 2023-374 - Rev 00	2025/10/22	Valid	22/10/2030	Chemical	2025/10/22	New application\|CEP granted\|22/10/2025
1002	Diclofenac sodium	HENAN DONGTAI PHARM CO., LTD. Anyang CN	100023192;100052097	CEP 2014-009 - Rev 01	2025/10/22	Valid		Chemical	2025/10/22	Major revision\|CEP granted\|22/10/2025; Renewal\|CEP granted\|21/12/2020; Major revision\|CEP granted\|03/06/2020
2217	Lamivudine, SVL Process	MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN	100051463;100098142	CEP 2014-034 - Rev 05	2025/10/22	Valid		Chemical	2025/10/22	Notification\|CEP granted\|22/10/2025; Transfer of holdership\|CEP granted\|25/07/2024; Minor revision\|CEP granted\|28/03/2024; Minor revision\|CEP granted\|30/08/2022; Major revision\|CEP granted\|16/11/2020
1508	Diclofenac potassium	HENAN DONGTAI PHARM CO., LTD. Anyang CN	100023192;100052097	CEP 2014-031 - Rev 01	2025/10/22	Valid		Chemical	2025/10/22	Major revision\|CEP granted\|22/10/2025; Renewal\|CEP granted\|08/03/2021; Major revision\|CEP granted\|03/06/2020
692	all-rac-alpha-Tocopherol	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2019-164 - Rev 02	2025/10/22	Valid		Chemical	2025/10/22	Renewal\|CEP granted\|22/10/2025; Notification\|CEP granted\|11/07/2025
1745	Carvedilol	MOEHS IBERICA S.L. Rubi ES	100029092;100068825	CEP 2002-089 - Rev 04	2025/10/22	Valid		Chemical	2025/10/22	Minor revision\|CEP granted\|22/10/2025; Minor revision\|Accepted - CEP remains valid\|28/02/2022; Minor revision\|Accepted - CEP remains valid\|19/11/2021
681	Pancuronium bromide	CURIA ITALY S.R.L. Rozzano, Milano IT	100032082;100050148	CEP 2005-120 - Rev 05	2025/10/22	Valid		Chemical	2025/10/22	Minor revision\|CEP granted\|22/10/2025; Notification\|Accepted - CEP remains valid\|14/12/2022; Notification\|CEP granted\|05/08/2021; Minor revision\|CEP granted\|20/07/2020
2606	Tadalafil	SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City CN	100048410;100080174	CEP 2025-131 - Rev 00	2025/10/22	Valid	22/10/2030	Chemical	2025/10/22	New application\|CEP granted\|22/10/2025
38	Levodopa, Enzymatic process	ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan Town CN	100024878;100034066	CEP 2021-195 - Rev 01	2025/10/22	Valid	12/10/2027	Chemical	2025/10/22	Minor revision\|CEP granted\|22/10/2025; Minor revision\|Accepted - CEP remains valid\|23/04/2025; Minor revision\|Accepted - CEP remains valid\|23/11/2022; New application\|CEP granted\|12/10/2022
1998	Nicergoline	SICHUAN RENAN PHARMACEUTICAL CO., LTD. Yuechi CN	100033464;100052360	CEP 2023-241 - Rev 00	2025/10/22	Valid	22/10/2030	Chemical	2025/10/22	New application\|CEP granted\|22/10/2025
2191	Atorvastatin calcium, Process II	NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN	100030313;100047776	CEP 2024-120 - Rev 01	2025/10/22	Valid	18/09/2029	Chemical	2025/10/22	Monograph revision\|CEP granted\|22/10/2025; New application\|CEP granted\|18/09/2024
2858	Mometasone furoate monohydrate, Crystalline Form, micronised	NEWCHEM S.p.A. Milano IT	100017847;100080332	CEP 2024-348 - Rev 01	2025/10/22	Valid	17/10/2029	Chemical	2025/10/22	Minor revision\|CEP granted\|22/10/2025; New application\|CEP granted\|17/10/2024
1705	Sertraline hydrochloride, Form I	R.L. FINE CHEM PRIVATE LIMITED Chikkaballapur IN	100016723;100053383	CEP 2024-495 - Rev 00	2025/10/22	Valid	22/10/2030	Chemical	2025/10/22	New application\|CEP granted\|22/10/2025
1244	Morphine hemisulfate 2.5-hydrate	FRANCOPIA Paris FR	100041331;100098338	CEP 2000-126 - Rev 08	2025/10/21	Valid		Chemical	2025/10/21	Notification\|CEP granted\|21/10/2025; Monograph revision\|CEP granted\|26/04/2024; Notification\|CEP granted\|01/03/2024; Notification\|CEP granted\|02/05/2022; Notification\|Accepted - CEP remains valid\|20/02/2020
3078	Riociguat, Micronised and non-micronised	MSN LIFE SCIENCES PRIVATE LIMITED Medak IN	100018316;100027671	CEP 2023-245 - Rev 00	2025/10/21	Valid	21/10/2030	Chemical	2025/10/21	New application\|CEP granted\|21/10/2025
1793	Oxycodone hydrochloride	FRANCOPIA Paris FR	100041331;100098338	CEP 2008-249 - Rev 04	2025/10/20	Valid		Chemical	2025/10/20	Notification\|CEP granted\|20/10/2025; Minor revision\|Accepted - CEP remains valid\|19/04/2024; Notification\|CEP granted\|01/03/2024; Notification\|CEP granted\|02/05/2022; Minor revision\|Accepted - CEP remains valid\|01/04/2020
97	Morphine hydrochloride trihydrate	FRANCOPIA Paris FR	100041331;100098338	CEP 2008-208 - Rev 05	2025/10/20	Valid		Chemical	2025/10/20	Notification\|CEP granted\|20/10/2025; Monograph revision\|CEP granted\|25/04/2024; Notification\|CEP granted\|01/03/2024; Notification\|Accepted - CEP remains valid\|22/11/2023; Transfer of holdership\|CEP granted\|25/05/2022
729	Naloxone hydrochloride dihydrate	FRANCOPIA Paris FR	100041331;100098338	CEP 1996-050 - Rev 08	2025/10/20	Valid		Chemical	2025/10/20	Notification\|CEP granted\|20/10/2025; Notification\|CEP granted\|22/02/2024; Major revision\|Accepted - CEP remains valid\|24/10/2023; Notification\|Accepted - CEP remains valid\|06/02/2023; Notification\|CEP granted\|02/05/2022; Minor revision\|Accepted - CEP remains valid\|10/08/2020

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-